174 related articles for article (PubMed ID: 33930994)
1. Cost-effectiveness of childhood influenza vaccination in Europe: results from a systematic review.
Boccalini S; Bechini A; Moscadelli A; Paoli S; Schirripa A; Bonanni P
Expert Rev Pharmacoecon Outcomes Res; 2021 Oct; 21(5):911-922. PubMed ID: 33930994
[No Abstract] [Full Text] [Related]
2. A systematic review of the health economic consequences of quadrivalent influenza vaccination.
de Boer PT; van Maanen BM; Damm O; Ultsch B; Dolk FCK; Crépey P; Pitman R; Wilschut JC; Postma MJ
Expert Rev Pharmacoecon Outcomes Res; 2017 Jun; 17(3):249-265. PubMed ID: 28613092
[TBL] [Abstract][Full Text] [Related]
3. Assessing optimal use of the standard dose adjuvanted trivalent seasonal influenza vaccine in the elderly.
Thorrington D; van Leeuwen E; Ramsay M; Pebody R; Baguelin M
Vaccine; 2019 Apr; 37(15):2051-2056. PubMed ID: 30871927
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of quadrivalent versus trivalent influenza vaccine in Taiwan: A lifetime multi-cohort model.
Yang MC; Tan EC; Su JJ
Hum Vaccin Immunother; 2017 Jan; 13(1):81-89. PubMed ID: 27624648
[TBL] [Abstract][Full Text] [Related]
5. Impact of quadrivalent influenza vaccines in Brazil: a cost-effectiveness analysis using an influenza transmission model.
Crépey P; Boiron L; Araujo RR; Lopez JG; Petitjean A; de Albuquerque Luna EJ
BMC Public Health; 2020 Sep; 20(1):1374. PubMed ID: 32907562
[TBL] [Abstract][Full Text] [Related]
6. Costs and effectiveness of influenza vaccination: a systematic review.
D'Angiolella LS; Lafranconi A; Cortesi PA; Rota S; Cesana G; Mantovani LG
Ann Ist Super Sanita; 2018; 54(1):49-57. PubMed ID: 29616674
[TBL] [Abstract][Full Text] [Related]
7. Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands.
de Boer PT; Nagy L; Dolk FCK; Wilschut JC; Pitman R; Postma MJ
Value Health; 2021 Jan; 24(1):19-31. PubMed ID: 33431149
[TBL] [Abstract][Full Text] [Related]
8. The Clinical Impact and Cost Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in Finland.
Nagy L; Heikkinen T; Sackeyfio A; Pitman R
Pharmacoeconomics; 2016 Sep; 34(9):939-51. PubMed ID: 27423657
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of different seasonal influenza vaccines in the elderly Italian population.
Capri S; Barbieri M; de Waure C; Boccalini S; Panatto D
Hum Vaccin Immunother; 2018 Jun; 14(6):1331-1341. PubMed ID: 29425079
[TBL] [Abstract][Full Text] [Related]
10. Key issues and challenges in estimating the impact and cost-effectiveness of quadrivalent influenza vaccination.
Quinn E; Jit M; Newall AT
Expert Rev Pharmacoecon Outcomes Res; 2014 Jun; 14(3):425-35. PubMed ID: 24734967
[TBL] [Abstract][Full Text] [Related]
11. Influenza cost and cost-effectiveness studies globally--a review.
Peasah SK; Azziz-Baumgartner E; Breese J; Meltzer MI; Widdowson MA
Vaccine; 2013 Nov; 31(46):5339-48. PubMed ID: 24055351
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom.
Thommes EW; Ismaila A; Chit A; Meier G; Bauch CT
BMC Infect Dis; 2015 Oct; 15():465. PubMed ID: 26503131
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of vaccinations and decision makings on vaccination programmes in Hong Kong: A systematic review.
Wong CKH; Liao Q; Guo VYW; Xin Y; Lam CLK
Vaccine; 2017 May; 35(24):3153-3161. PubMed ID: 28476628
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of Strategies for Offering Influenza Vaccine in the Pediatric Emergency Department.
Hart RJ; Stevenson MD; Smith MJ; LaJoie AS; Cross K
JAMA Pediatr; 2018 Jan; 172(1):e173879. PubMed ID: 29114729
[TBL] [Abstract][Full Text] [Related]
15. Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea.
Kim YK; Song JY; Jang H; Kim TH; Koo H; Varghese L; Han E
Pharmacoeconomics; 2018 Dec; 36(12):1475-1490. PubMed ID: 30251078
[TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness of Routine Childhood Vaccination Against Seasonal Influenza in Germany.
Scholz SM; Weidemann F; Damm O; Ultsch B; Greiner W; Wichmann O
Value Health; 2021 Jan; 24(1):32-40. PubMed ID: 33431151
[TBL] [Abstract][Full Text] [Related]
17. Use of adjuvanted trivalent influenza vaccine in older-age adults: a systematic review of economic evidence.
Loperto I; Simonetti A; Nardone A; Triassi M
Hum Vaccin Immunother; 2019; 15(5):1035-1047. PubMed ID: 30735465
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of adult vaccinations: A systematic review.
Leidner AJ; Murthy N; Chesson HW; Biggerstaff M; Stoecker C; Harris AM; Acosta A; Dooling K; Bridges CB
Vaccine; 2019 Jan; 37(2):226-234. PubMed ID: 30527660
[TBL] [Abstract][Full Text] [Related]
19. [Cost-effectiveness of vaccines for the prevention of seasonal influenza in different age groups: a systematic review].
Valcárcel Nazco C; García Lorenzo B; Del Pino Sedeño T; García Pérez L; Brito García N; Linertová R; Ferrer Rodríguez J; Imaz Iglesia I; Serrano Aguilar P
Rev Esp Salud Publica; 2018 Oct; 92():. PubMed ID: 30327454
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of quadrivalent versus trivalent influenza vaccine for elderly population in China.
Jiang M; Li P; Wang W; Zhao M; Atif N; Zhu S; Fang Y
Vaccine; 2020 Jan; 38(5):1057-1064. PubMed ID: 31787414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
